BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6517862)

  • 1. Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
    Basu A; Glew RH
    Biochem J; 1984 Dec; 224(2):515-24. PubMed ID: 6517862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
    Basu A; Glew RH
    J Biol Chem; 1985 Oct; 260(24):13067-73. PubMed ID: 3932339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.
    Prence EM
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):571-5. PubMed ID: 7654196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the ability of phospholipids from rat liver lysosomes to reconstitute glucocerebrosidase.
    Basu A; Glew RH; Wherrett JR; Huterer S
    Arch Biochem Biophys; 1986 Mar; 245(2):464-9. PubMed ID: 3954363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB; Glew RH; Radin NS; Vunnam RR
    Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
    Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
    Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
    Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
    Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
    Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein).
    Berent SL; Radin NS
    Biochim Biophys Acta; 1981 Jun; 664(3):572-82. PubMed ID: 6268176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
    J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calmodulin and parvalbumin: activators of human liver glucocerebrosidase.
    Glew RH; Coffee CJ
    Arch Biochem Biophys; 1984 Feb; 229(1):55-63. PubMed ID: 6422854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
    Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA; Osiecki-Newman K; Dinur T; Fabbro D; Legler G; Gatt S; Desnick RJ
    J Biol Chem; 1986 Jun; 261(18):8263-9. PubMed ID: 3087971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.